Evidence map›Paper›PMID 23762483›Full record

ArticlePloS one2013

nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa.

Mariela R Monti, Natalia R Morero, Virginia Miguel, Carlos E Argaraña

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Applicability of Nanopore-only whole-genome sequencing forJournal of clinical microbiology · 2026
    Article
  2. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Novel Fosfomycin Resistance Mechanism inAntibiotics (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Antimicrobial agents and chemotherapy · 2023
    Article
  9. Article
  10. The methylation-independent mismatch repair machinery inMicrobiology (Reading, England) · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Genetic Diversity of Multidrug-ResistantFrontiers in microbiology · 2021
    Article
  15. Real-Time Monitoring ofAntimicrobial agents and chemotherapy · 2017
    Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mariela R MontiCentro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC), CONICET, Departamento de Química Biológica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, Córdoba, Argentina.
Natalia R Morero
Virginia Miguel
Carlos E Argaraña

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

nfxB encodes a negative regulator of the mexCD-oprJ genes for drug efflux in the opportunistic pathogen Pseudomonas aeruginosa. Inactivating mutations in this transcriptional regulator constitute one of the main mechanisms of resistance to ciprofloxacin (Cip(r)). In this work, we evaluated the use of nfxB/Cip(r) as a new test system to study mutation spectra in P. aeruginosa. The analysis of 240 mutations in nfxB occurring spontaneously in the wild-type and mutator backgrounds or induced by mutagens showed that nfxB/Cip(r) offers several advantages compared with other mutation detection systems. Identification of nfxB mutations was easy since the entire open reading frame and its promoter region were sequenced from the chromosome using a single primer. Mutations detected in nfxB included all transitions and transversions, 1-bp deletions and insertions, >1-bp deletions and duplications. The broad mutation spectrum observed in nfxB relies on the selection of loss-of-function changes, as we confirmed by generating a structural model of the NfxB repressor and evaluating the significance of each detected mutation. The mutation spectra characterized in the mutS, mutT, mutY and mutM mutator backgrounds or induced by the mutagenic agents 2-aminopurine, cisplatin and hydrogen peroxide were in agreement with their predicted mutational specificities. Additionally, this system allowed the analysis of sequence context effects since point mutations occurred at 85 different sites distributed over the entire nfxB. Significant hotspots and preferred sequence contexts were observed for spontaneous and mutagen-induced mutation spectra. Finally, we demonstrated the utility of a luminescence-based reporter for identification of nfxB mutants previous to sequencing analysis. Thus, the nfxB/Cip(r) system in combination with the luminescent reporter may be a valuable tool for studying mutational processes in Pseudomonas spp. wherein the genes encoding the NfxB repressor and the associated efflux pump are conserved.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionBacterial ProteinsCiprofloxacinDNA-Binding ProteinsDrug Resistance, BacterialGenes, ReporterLuminescenceModels, MolecularMolecular Sequence DataMutagensMutationMutation RatePseudomonas aeruginosaSequence Analysis, DNATranscription FactorsBacterial ProteinsCiprofloxacinDNA-Binding ProteinsMutagensNfxB protein, Pseudomonas aeruginosaTranscription Factors

Identifiers

PMID23762483
PMCPMC3676378

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.